Canada: Double-Patenting: The Canadian Perspective For U.S. Practitioners

Since the Supreme Court of Canada decision in Whirlpool Corp. v. Camco Inc., 2000 SCC 67, double-patenting has become a common challenge to patent validity in Canada. The Canadian double-patenting doctrine is similar to the U.S. double-patenting doctrine, but subtle differences between the two can potentially lead to a fatal double-patenting issue for a Canadian patent that would otherwise be easily resolved for its U.S. counterpart under U.S. practice. Similarities and differences between the Canadian and U.S. double-patenting doctrines are discussed in this article and some strategies are identified for potentially mitigating double-patenting risks in Canada.

Contrast between Canadian and U.S. double-patenting laws. The Supreme Court of Canada held in Whirlpool (supra 157-159) that the prohibition against double-patenting has two separate "branches": (1) the "same invention" branch, also known as the "coterminousness" branch; and (2) the "obviousness" branch. The "same invention" branch will invalidate any claim of a pending application or issued patent that is identical in scope to a claim of an earlier-issued patent. This branch is similar to "statutory" or "same invention" double-patenting in the U.S. The "obviousness" branch will invalidate any claim of a pending application or issued patent that is not patentably distinct (novel and non-obvious) from any claim of an earlier issued patent. This branch is similar to the judicially created doctrine of obviousness-type double-patenting in the U.S.

In the U.S., "statutory" ("same invention") double-patenting is fatal, whereas obviousness-type double-patenting can be obviated with a terminal disclaimer. A terminal disclaimer disclaims the non-overlapping term of the later-issued patent and also provides that the later-issued patent will cease to be enforceable if it does not remain commonly owned with the earlier-issued patent. In contrast, Canadian patent law does not provide any equivalent to a U.S. terminal disclaimer. Both "branches" of double-patenting are equally fatal in Canada and no direct procedural remedy exists to cure either branch. Due to this difference, greater care must be taken to avoid "obviousness" double-patenting situations in Canada that may have been dealt with by way of a terminal disclaimer in the U.S. counterpart.

Like the U.S., if a Canadian examiner effectively forces the filing of a divisional application by raising a lack of unity of invention objection (equivalent to U.S. restriction/election requirement), then the claims retained in the parent and the claims divided out are immune from double-patenting attacks based on one another. However, Canadian practice differs from U.S. practice on this point in that the limited immunity provided under Canadian practice is purely based on Canadian case-law (Consolboard Inc. v. Macmillan Bloedel Ltd., [1981] 1 SCR 504), whereas the similar immunity provided under U.S. practice is conferred directly from statute by 35 U.S.C. §121.

Typical double-patenting problems. In general, potential double-patenting risks may arise in any situation where the claims of one application arguably fail to recite any further non-obvious element or limitation in comparison to the claims of another co-pending application or issued patent.

One common scenario in which obviousness-type double patenting can arise relates to selection patents. For example, an initial patent application may be filed with claims to a broad class or genus of compounds. Subsequent work may identify a specific compound or species within the genus that has some advantage over other compounds within the genus, and a selection patent application may be filed with claims for the narrower species. The Supreme Court of Canada ruling in Sanofi-Synthelabo Canada Inc. v. Apotex Inc., 2008 SCC 61, has confirmed that selection patents are not, per se invalid for lack of novelty, obviousness or double-patenting. In this decision, the Court found that there was no double patenting in a later issuing selection patent claiming clopidogrel and its hydrogen sulfate salt over an earlier issued patent of the same applicant that claimed the genus encompassing clopidogrel and its salts. However, it is not uncommon for a narrower species application to proceed through examination to issuance more quickly than the earlier filed genus application. In the U.S., if the later-filed species application were to issue first, the still-pending genus application may receive an obviousness-type double-patenting rejection which, as noted earlier, could be overcome by filing a terminal disclaimer. In contrast, no procedural equivalent to a terminal disclaimer exists in Canada.

A further example stems from the fact that Canadian law does not include any direct equivalent of U.S. continuation practice. While Canadian practice does permit the filing of voluntary divisional applications (Canadian Patent Act, Subsection 36(2)), care must be taken to ensure that the claims that issue for a voluntary divisional application are patentably distinct (novel and non-obvious) from the claims of the parent. This can be particularly problematic if a voluntary divisional is filed to pursue the claims of a corresponding U.S. continuation that includes claims that are broader than those of the parent. Due to the absence of any terminal disclaimer or equivalent remedy in Canada, the issuance of the narrower parent claims while the broader divisional claims are still pending could prove fatal to those broader divisional claims.

Another common scenario arises when multiple applications with substantially identical disclosures but different claim sets are filed on the same day. Even if the independent claims of each application are directed to a different inventive concept than the independent claims of the other applications, the dependent claims often combine the various inventive concepts together, leading to double-patenting problems when one of the applications issues.

Strategies for avoiding double patenting problems. From a foreign practitioner's standpoint, a proactive measure to avoid double-patenting problems in Canada is to consolidate all related applications for the same applicant or assignee with a single Canadian patent agent and to inform the Canadian patent agent of the relationship. Even the most diligent Canadian practitioner will be unable to proactively avoid double-patenting problems if he or she is unaware that a related application is being prosecuted by another firm.

Developments in the prosecution of U.S. and other foreign counterpart and related applications may also serve as alarm bells to indicate that a review of related Canadian applications would be beneficial. In particular, whenever a terminal disclaimer is filed in the U.S., informing the Canadian agent and instructing him or her to conduct an immediate comparison of the two corresponding Canadian applications may be beneficial, to assess whether the absence of any equivalent terminal disclaimer procedure in Canada may pose obviousness-type double-patenting risks.

Claim consolidation is a valuable strategy for avoiding double-patenting problems in situations where multiple claim sets are supported by the specification of a single application. This may include situations involving a parent application and its pending or proposed divisional application, or situations involving multiple applications with substantially identical disclosures filed on the same day. Combining two desired claim sets into a single application will result in the examiner either allowing both claim sets to co-exist in the same application, or issuing a unity objection. The unity objection would then permit a divisional application to be filed, and the divisional and its parent would then enjoy a judicial immunity against double-patenting attack which they would not have enjoyed if the divisional had been voluntarily filed without any such objection. In either case, double-patenting risks are avoided.

For other situations, there are procedural mechanisms available under Canadian practice to control the relative timing of the applications. This control can be used to cause a broader "genus" application to issue before a narrower "species" application, thereby ensuring that the later-issued claims are inventive over the earlier-issued claims. The control of the timing of applications can also be used to keep a parent patent application pending as long as possible, until the applicant has determined all of the claims the applicant ultimately wants to pursue. The claims can then be consolidated into the parent application as discussed above, rather than filing a voluntary divisional application.

To control the relative timing of applications, a number of techniques are available to accelerate or decelerate the examination of an application. For example, one technique for decelerating examination is to defer the request for examination. Examination in Canada does not have to be requested until five years after the filing date.

Delaying the examination of an application may, however, be detrimental in the rare, though possible, situation where double patenting arises with a third party application or patent.

Conversely, techniques for accelerating examination are discussed in the concurrently published article titled, "Amendments to Canadian Patent Rules and Office practice bring opportunities for expedited patent examination", by Daphne C. Lainson.

Conclusions. Unwary applicants may face risks associated with one or more of the unique aspects of Canadian double-patenting laws. Fortunately, procedural mechanisms, such as those discussed above, are available to mitigate these risks.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Bereskin & Parr LLP
Smart & Biggar/Fetherstonhaugh
Borden Ladner Gervais LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Bereskin & Parr LLP
Smart & Biggar/Fetherstonhaugh
Borden Ladner Gervais LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions